MyFinsight
Home
Blog
About
Back
Income Statement
Edesa Biotech, Inc. (EDSA)
Edesa Biotech, Inc. (EDSA)
source: myfinsight.com
Net comprehensive
loss
-$5,380,063
(-239.47%↓ Y/Y)
Exchange differences on
translation
$27,548
(-83.26%↓ Y/Y)
Net loss
-$5,407,611
(-209.10%↓ Y/Y)
Reimbursement grant income
$107,368
(-41.42%↓ Y/Y)
Foreign exchange gain
$4,295
(114.52%↑ Y/Y)
Interest income
$275
(-51.92%↓ Y/Y)
Loss before income
taxes
-$5,407,611
(-209.10%↓ Y/Y)
Nonoperating income
(expense)
$111,938
(-27.44%↓ Y/Y)
Loss from operations
-$5,519,549
(-189.93%↓ Y/Y)
Research and development
$3,957,875
(321.47%↑ Y/Y)
General and
administrative
$1,561,674
(61.89%↑ Y/Y)
Back